SBIR/STTR Research Award

SEVERAL PROPERTIES OF PHOSPHAZENE POLYMERS [R(2)PN]X APPEAR IDEAL FOR THE IMMUNOGENIC DELIVERY OF A WIDE VARIETY OF ANTIGENS.

Award identifier 526d226672a42608107425cb721eb19923ff4e331e9303017b534d78bdeb0937Awarding agency Department of Health and Human Services

Award amount

$35,000

Program and phase

SBIR · Phase I

Award year

1983

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Inland Laboratorytories
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

SEVERAL PROPERTIES OF PHOSPHAZENE POLYMERS [R(2)PN]X APPEAR IDEAL FOR THE IMMUNOGENIC DELIVERY OF A WIDE VARIETY OF ANTIGENS. FIRST, THEY READILY FORM COVALENT LINKAGES WITH THOSE REACTIVE GROUPS COMMON TO POLYPEPTIDES, CARBOHYDRATES,AND MANY SMALL ORGANIC MOLECULES. SECOND, AT PHYSIOLOGIC PHTHE CONTROLLED HYDROLYSIS OF THE P-N BONDS RESULTS IN FRAGMENTATION OF THE POLYMER AND THE CONCOMITANT RELEASE OF SMALLER (- P-N -)X UNITS. THIRD, THE DEGRADATION PRODUCTS OF THE POLYMER ARE NON-TOXIC. PHOSPHAZENE POLYMERS PARTIALLY SUBSTITUTED WITH HAPTENS AND PROTEIN WILL BE SYNTHESIZED AND INJECTED INTO MICE. EVIDENCE OF A CELLULAR AND/OR HUMORAL RESPONSE WILL THEN BE INVESTIGATED. ESTABLISHING THE EFFECTIVENESS OF THIS ANTIGEN DELIVERY SYSTEM IS AN IMPORTANT STEP IN DETERMINING ITS SUITABILITY FOR A WIDE VARIETY OF IMMUNOLOGIC APPLICATIONS. AS AN ADJUVANT, PHOSPHAZENES WOULD ALLOW THE STEADY RELEASE OF ANTIGENS COVALENTLY ATTACHED TO THE POLYMER. EXPERIMENTS TESTING THE USEFULNESS OF POLYPHOSPHAZENES AS ADJUVANTS WOULD BE OF SPECIAL INTEREST. PHOSPHAZENES COULD ALSO BE USED FOR THE ANTIGENIC MODIFICATION OF THE TUMOR CELL SURFACE. APPLICATION OF A PARTIALLY HAPTENATED PHOSPHAZENE TO THE TUMOR CELL SURFACE COULD COVALENTLY LINK HAPTENS TO TUMOR-SPECIFIC ANTIGENS VIA THE PHOSPHAZENE POLYMER. THIS COULD CREATE NEW, HIGHLY IMMUNOGENIC DETERMINANTS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.